6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1,8-naphthyridin-2(1H)-one, 98%, 100mg

5-Chloro-2-trifluoromethylpyrazine, 95.0%, 250mg

Ethylenediamine tetraacetic acid, min. 99%, 250 g, plastic packaging.

5-Bromo-4-(trifluoromethyl)pyrimidine, 95.0%, 100mg

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 10mg

N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide, 10mg

endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ol, 98.0%, 25g

3-Phenyl-benzo[c]isoxazole-5-carboxylic acid, 95.0%, 1g

2-Ethylsulfanyl-1H-benzoimidazole, 97.0%, 1g

2-Bromo-5,6-dichloropyridin-3-amine, 95.0%, 500mg

Methyl 4-bromo-3-formylbenzoate, 95.0%, 100g

2-Chloro-5-(pentafluorosulfur)benzoyl chloride, 1g

N-(2-Mercaptopropionyl)glycine, 98.0%, 5g